Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 1127-1137

  Lehman, Susan M ^a,b   Donlan, Rodney M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b AmpliPhi Biosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIOPHAGE; BIOFILM; CATHETER INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; HYDROGEL; IN VITRO STUDY; INDWELLING URINARY CATHETER; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SEWAGE; URINARY TRACT INFECTION; URINE CULTURE; ADVERSE EFFECTS; BLADDER CATHETERIZATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; URINARY CATHETER; VIROLOGY;

BACTERIOPHAGES; BIOFILMS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; URINARY CATHETERIZATION; URINARY CATHETERS;

EID: 84921917258     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03786-14     Document Type: Article

References (70)

1. Magill SS, Edwards JR, Bamberg W, Beldavs MS, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. 2014. Multistate point-prevalence survey of health careassociated infections. N Engl J Med 370:1198-1208. http://dx.doi.org/10 .1056/NEJMoa1306801.
2. Saint S. 2000. Clinical and economic consequences of nosocomial cathe-ter-related bacteriuria. Am J Infect Control 28:68-75. http://dx.doi.org /10.1016/S0196-6553(00)90015-4.
3. Tambyah PA, Knasinski V, Maki DG. 2002. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 23:27-31. http://dx.doi.org/10.1086 /501964.
4. Garibaldi RA, Mooney BR, Epstein BJ, Britt MR. 1982. An evaluation of daily bacteriologic monitoring to identify preventable episodes of cathe-ter-associated urinary tract infection. Infect Control 3:466-470.
5. Ganderton L, Chawla J, Winters C, Wimpenny J, Stickler D. 1992. Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. Eur J Clin Microbiol Infect Dis 11:789-796. http://dx.doi.org /10.1007/BF01960877.
6. Frank DN, Wilson SS, St. Amand AL, Pace NR. 2009. Cultureindependent microbiological analysis of Foley urinary catheter biofilms. PLoS One 4:e7811. http://dx.doi.org/10.1371/journal.pone.0007811.
7. Daifuku R, Stamm WE. 1984. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA 252:2028-2030. http://dx.doi.org/10.1001/jama.1984.0335015002 8015.
8. Tambyah PA, Halvorson KT, Maki DG. 1999. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 74:131-136. http://dx.doi.org/10.4065/74.2.131.
9. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, National Healthcare Safety Network Team, Participating National Healthcare Safety Network Facilities. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29:996-1011. http://dx .doi.org/10.1086/591861.
10. Wagenlehner FM, Weidner W, Naber KG. 2005. Emergence of antibiotic resistance amongst hospital-acquired urinary tract infections and pharmacokinetic/ pharmacodynamic considerations. J Hosp Infect 60:191-200. http://dx.doi.org/10.1016/j.jhin.2004.12.017.
11. Jarvis WR, Martone WJ. 1992. Predominant pathogens in hospital infections. J Antimicrob Chemother 29(Suppl A):19-24.
12. Gaynes RP, Weinstein RA, Chamberlin W, Kabins SA. 1985. Antibioticresistant flora in nursing home patients admitted to the hospital. Arch Intern Med 145:1804-1807. http://dx.doi.org/10.1001/archinte.1985.003 60100064009.
13. Raz R. 2000. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol 164:1254-1258. http://dx.doi.org/10.1016/S0022-5347(05)67150-9.
14. Clayton CL, Chawla JC, Stickler DJ. 1982. Some observations on urinary tract infections in patients undergoing long-term bladder catheterization. J Hosp Infect 3:39-47. http://dx.doi.org/10.1016/0195-6701(82)90029-9.
15. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx .doi.org/10.1126/science.284.5418.1318.
16. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA, Healthcare Infection Control Practices Advisory Committee (HICPAC). 2009. Guideline for prevention of catheter-associated urinary tract infections 2009. Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention (CDC), Atlanta, GA. http://www .cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf.
17. Reddy ST, Chung KK, McDaniel CJ, Darouiche RO, Landman J, Brennan AB. 2011. Micropatterned surfaces for reducing the risk of catheterassociated urinary tract infection: an in vitro study on the effect of Sharklet micropatterned surfaces to inhibit bacterial colonization and migration of uropathogenic Escherichia coli. J Endourol 25:1547-1552. http://dx.doi .org/10.1089/end.2010.0611.
18. Kappell GM, Grover JP, Chrzanowski TH. 2009. Micro-scale surfacepatterning influences biofilm formation. Electron J Biotechnol 12:e8. http: //dx.doi.org/10.2225/vol12-issue3-fulltext-8.
19. Hook AL, Chang CY, Yang J, Luckett J, Cockayne A, Atkinson S, Mei Y, Bayston R, Irvine DJ, Langer R, Anderson DG, Williams P, Davies MC, Alexander MR. 2012. Combinatorial discovery of polymers resistant to bacterial attachment. Nat Biotechnol 30:868-875. http://dx.doi.org/10 .1038/nbt.2316.
20. Jones GL, Muller CT, O'Reilly M, Stickler DJ. 2006. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J Antimicrob Chemother 57:266-272. http://dx.doi.org/10 .1093/jac/dki447.
21. Williams GJ, Stickler DJ. 2007. Some observations on the diffusion of antimicrobial agents through the retention balloons of Foley catheters. J Urol 178:697-701. http://dx.doi.org/10.1016/j.juro.2007.03.091.
22. Trautner BW, Hull RA, Thornby JI, Darouiche RO. 2007. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol 28: 92-94. http://dx.doi.org/10.1086/510872.
23. Prasad A, Cevallos ME, Riosa S, Darouiche RO, Trautner BW. 2009. A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization. Spinal Cord 47:565-569. http://dx.doi.org /10.1038/sc.2008.166.
24. Cho YH, Lee SJ, Lee JY, Kim SW, Kwon IC, Chung SY, Yoon MS. 2001. Prophylactic efficacy of a new gentamicin-releasing urethral catheter in short-term catheterized rabbits. BJU Int 87:104-109. http://dx.doi.org/10 .1046/j.1464-410x.2001.00978.x.
25. Hachem R, Reitzel R, Borne A, Jiang Y, Tinkey P, Uthamanthil R, Chandra J, Ghannoum M, Raad I. 2009. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother 53:5145-5149. http://dx .doi.org/10.1128/AAC.00718-09.
26. Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S. 2008. Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens. J Antimicrob Chemother 61:651-657. http: //dx.doi.org/10.1093/jac/dkn006.
27. Kowalczuk D, Ginalska G, Golus J. 2010. Characterization of the developed antimicrobial urological catheters. Int J Pharm 402:175-183. http: //dx.doi.org/10.1016/j.ijpharm.2010.10.014.
28. Regev-Shoshani G, Ko M, Miller C, Av-Gay Y. 2010. Slow release of nitric oxide from charged catheters and its effect on biofilm formation by Escherichia coli. Antimicrob Agents Chemother 54:273-279. http://dx.doi .org/10.1128/AAC.00511-09.
29. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. 1998. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 105:236-241. http://dx.doi.org/10 .1016/S0002-9343(98)00240-X.
30. Lai KK, Fontecchio SA. 2002. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control 30:221-225. http://dx.doi.org/10.1067 /mic.2002.120128.
31. Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, Fey PD. 2004. Effect of silver-coated urinary catheters: efficacy, costeffectiveness, and antimicrobial resistance. Am J Infect Control 32:445-450. http://dx.doi.org/10.1016/j.ajic.2004.05.002.
32. Stensballe J, Tvede M, Looms D, Lippert FK, Dahl B, Tønnesen E, Rasmussen LS. 2007. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann Intern Med 147:285-293. http://dx.doi.org/10.7326/0003-4819-147-5-200709040-00002.
33. Desai DG, Liao KS, Cevallos ME, Trautner BW. 2010. Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence. J Urol 184:2565-2571. http://dx.doi.org/10.1016/j .juro.2010.07.036.
34. Park JH, Cho YW, Cho YH, Choi JM, Shin HJ, Bae YH, Chung H, Jeong SY, Kwon IC. 2003. Norfloxacin-releasing urethral catheter for long-term catheterization. J Biomater Sci Polym Ed 14:951-962. http://dx .doi.org/10.1163/156856203322381438.
35. Schumm K, Lam TB. 2008. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2008 (2) :CD004013. http://dx.doi.org/10 .1002/14651858.CD004013.pub3.
36. Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazner C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N=Dow J. 2012. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicenter randomised controlled trial. Lancet 380:1927-1935. http://dx.doi.org/10 .1016/S0140-6736(12)61380-4.
37. Curtin JJ, Donlan RM. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50:1268-1275. http://dx.doi.org/10.1128/AAC.50.4 .1268-1275.2006.
38. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. 2010. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54: 397-404. http://dx.doi.org/10.1128 /AAC.00669-09.
39. Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R, Merril CR. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 70:204-210. http://dx.doi.org/10.1128/IAI.70.1.204-210.2002.
40. Chanishvili N, Chanishvili T, Tediashvili M, Barrow PA. 2001. Phages and their application against drug-resistant bacteria. J Chem Technol Biotechnol 76:689-699. http://dx.doi.org/10.1002/jctb.438.
41. Macleod SM, Stickler DJ. 2007. Species interactions in mixedcommunity crystalline biofilms on urinary catheters. J Med Microbiol 56:1549-1557. http://dx.doi.org/10.1099/jmm.0.47395-0.
42. Tambyah PA, Maki DG. 2000. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med 160:673-677. http://dx.doi.org/10.1001 /archinte.160.5.673.
43. Martin C, Ichou MA, Massicot P, Goudeau A, Quentin R. 1995. Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J Clin Microbiol 33:1461-1466.
44. Drenkard E, Ausubel FM. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743. http://dx.doi.org/10.1038/416740a.
45. Liao KS, Lehman SM, Tweardy DJ, Donlan RM, Trautner BW. 2012. Bacteriophages are synergistic with bacterial interference for the prevention of Pseudomonas aeruginosa biofilm formation on urinary catheters. J Appl Microbiol 113:1530-1539. http://dx.doi.org/10.1111/j.1365-2672 .2012.05432.x.
46. Warren JW. 1996. Clinical presentations and epidemiology of urinary tract infections, p 3-27. In Mobley HLT, Warren JW (ed), Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, DC.
47. Kunin CM. 1997. Care of the urinary catheter, p 226-278. Urinary tract infections: detection, prevention and management. Williams & Wilkins, Baltimore, MD.
48. Stickler DJ, Zimakoff J. 1994. Complications of urinary tract infections associated with devices used for long-term bladder management. J Hosp Infect 28:177-194. http://dx.doi.org/10.1016/0195-6701(94)90101-5.
49. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21:26-59. http://dx.doi.org/10.1128 /CMR.00019-07.
50. Brooks T, Keevil CW. 1997. A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol 24:203-206. http://dx.doi.org/10 .1046/j.1472-765X.1997.00378.x.
51. Appelmans R. 1921. De dosage du bactériophage. C R Soc Biol 85:1098.
52. Adams M. 1959. Bacteriophages. Interscience Publishers, London, United Kingdom.
53. O'Toole GA, Kolter R. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28:449-461. http://dx.doi.org /10.1046/j.1365-2958.1998.00797.x.
54. Smith K, Hunter IS. 2008. Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates. J Med Microbiol 57:966-973. http://dx.doi.org/10.1099/jmm.0.47668-0.
55. Stickler DJ, Morris NS, Winters C. 1999. Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods Enzymol 310:494-501. http://dx.doi.org/10.1016/S0076-6879(99)10037-5.
56. Chutipongtanate S, Thongboonkerd V. 2010. Systematic comparisons of artificial urine formulas for in vitro cellular study. Anal Biochem 402:110-112. http://dx.doi.org/10.1016/j.ab.2010.03.031.
57. Griffith DP, Musher DM, Itin C. 1976. Urease. The primary cause of infection-induced urinary stones. Invest Urol 13:346-350.
58. Cox AJ, Hukins DW, Davies KE, Irlam JC, Sutton TM. 1987. An automated technique for in vitro assessment of the susceptibility of urinary catheter materials to encrustation. Eng Med 16:37-41. http://dx.doi.org /10.1243/EMED&-JOUR-1987-016-009-02.
59. Jones SM, Yerly J, Hu Y, Ceri H, Martinuzzi R. 2007. Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. FEMS Microbiol Lett 268:16-21. http://dx.doi.org/10.1111/j.1574 -6968.2006.00587.x.
60. Tait K, Skillman LC, Sutherland IW. 2002. The efficacy of bacteriophage as a method of biofilm eradication. Biofouling 18:305-311. http://dx.doi .org/10.1080/0892701021000034418.
61. Sillankorva S, Neubauer P, Azeredo J. 2010. Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling 26:567-575. http://dx.doi.org/10.1080/08927014.2010.494251.
62. Kay MK, Erwin TC, McLean RJ, Aron GM. 2011. Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities. Appl Environ Microbiol 77:821-829. http://dx.doi.org/10.1128/AEM .01797-10.
63. Burmolle M, Webb JS, Rao D, Hansen LH, Sørensen SJ, Kjelleberg S. 2006. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol 72:3916-3923. http://dx .doi.org/10.1128/AEM.03022-05.
64. Skillman LC, Sutherland IW, Jones MV. 1999. The role of exopolysaccharides in dual species biofilm development. J Appl Microbiol 85(Suppl 1):13S-18S.
65. Schrag SJ, Mittler JE. 1996. Host-parasite coexistence: the role of spatial refuges in stabilizing bacteria-phage interactions. Am Nat 148:348-377. http://dx.doi.org/10.1086/285929.
66. Hull RA, Donovan WH, Del Terzo M, Stewart C, Rogers M, Darouiche RO. 2002. Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 70:6481-6484. http://dx.doi.org/10.1128/IAI.70.11.6481-6484 .2002.
67. Trautner BW, Darouiche RO, Hull RA, Hull S, Thornby JI. 2002. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol 167:375-379. http: //dx.doi.org/10.1016/S0022-5347(05)65471-7.
68. Trautner BW, Hull RA, Darouiche RO. 2003. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 61:1059-1062. http://dx.doi.org/10.1016/S0090-4295(02)02555-4.
69. Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA. 2005. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 41:1531-1534. http://dx.doi.org/10.1086/497272.
70. Lindberg RB, Latta RL. 1974. Phage typing of Pseudomonas aeruginosa: clinical and epidemiologic considerations. J Infect Dis 130:S33-S42. http: //dx.doi.org/10.1093/infdis/130.Supplement.S33.